Role of serotonin and noradrenaline in stress urinary incontinence.
Michel
M C
MC
Department of Pharmacology and Pharmacotherapy, University of Amsterdam, Amsterdam, the Netherlands. m.c.michel@amc.uva.nl
Peters
S L M
SL
D018759:Adrenergic Uptake Inhibitors / Q000008:administration & dosage; D002490:Central Nervous System / Q000502:physiology; D004305:Dose-Response Relationship, Drug; D000068736:Duloxetine Hydrochloride; D005260:Female; D006801:Humans; D009638:Norepinephrine / Q000502:physiology*; D017933:Peripheral Nervous System / Q000502:physiology; D012701:Serotonin / Q000502:physiology*; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage; D013876:Thiophenes / Q000627:therapeutic use; D001743:Urinary Bladder / Q000187:drug effects / Q000502:physiology; D014550:Urinary Incontinence, Stress / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology*; D014554:Urination / Q000502:physiology
D018759:Adrenergic Uptake Inhibitors; D000068736:Duloxetine Hydrochloride; D009638:Norepinephrine; D012701:Serotonin; D017367:Selective Serotonin Reuptake Inhibitors; D013876:Thiophenes